Most patients with partial intestinal obstruction can be managed without surgical intervention. Here, we report the case of a patient who presented with partial intestinal obstruction. He had been diagnosed with high-grade urothelial cell carcinoma (UCC) 1.5 years previously, for which the surgery and adjuvant chemotherapy had been successfully performed. He showed a poor response to medical treatment for the partial intestinal obstruction, and surgery provided only a short-term benefit. Such cases of intractable small-bowel obstruction are infrequent and pose a challenge to clinicians. Although very rare, the possibility of UCC metastasis to the gastrointestinal tract should be considered in the differential diagnosis of refractory intestinal obstruction and history of UCC.
Herein, we report one case of a patient who experienced recurrent partial SBO caused by metastatic urothelial cell carcinoma (UCC) to the distal ileum complicated with bowel paralysis. Such cases of partial SBO are very rare and difficult to manage.
CASE REPORT
A 71-year-old male presented with abdominal pain for days, with no passage of stool for about 1 week. Tympanic sounds could be heard on percussion of the abdomen, and there were no signs of peritonitis. An abdominal plain radiograph revealed intestinal obstruction [ Figure 1a ].
The patient had been diagnosed with UCC of the left ureter 1.5 years previously, which presented as painless gross hematuria.
Hand-assisted retroperitoneoscopic nephroureterectomy with excision of the bladder cuff and
INTRODUCTION
The leading cause of small-bowel obstruction (SBO) is postsurgical intervention-related intraperitoneal adhesion. 1, 2 Inflammatory and malignancy diseases are rarely associated with SBO, with malignant bowel obstruction accounting for <10% of cases. 1 In most such cases, the small intestine is obstructed by extrinsic compression or local invasion of advanced gynecologic or gastrointestinal malignancies. 1, 3 The initial management of SBO comprises nothing by mouth, fluid resuscitation, placement of a nasogastric (NG) tube for decompression, and administration of analgesia or antiemetic, depending on the clinical condition. Symptoms in most patients resolve within 3 days after nonoperative treatment. A previous study reported successful symptoms resolution without peritonitis in 65%-81% of cases with nonoperative management of partial intestinal obstruction. 4
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left pelvic lymph node dissection had been performed. The pathologic diagnosis was found to be high-grade UCC, pT3N1M0, and Stage IV. The tumor had been found to invade the periureteric fat, the cut end of the ureter, and the paraexternal iliac lymph nodes. Lymphovascular space invasion (LVSI) had also been noted. Postoperative adjuvant chemotherapy with carboplatin/gemcitabine had been administered, and up to this presentation, follow-up with abdominal magnetic resonance imaging and cystoscopy had not shown any evidence of a recurrent lesion.
The patient's symptoms improved with fasting and NG tube insertion with decompression, but an abdominal plain radiograph still showed a stack of coins' sign [ Figure 1b ]. Due to the poor response to medical treatment for 19 days, the patient received surgery to relieve the obstruction.
During the operation, no peritoneal carcinomatosis was noted, but a distended small intestine [ Figure 2a ] and one tumor-like lesion at the distal ileum which near the previous surgical area [ Figure 2b ] were noted. There was involvement of paraexternal iliac lymph nodes. The tumor-like lesion was resected, and immunohistochemical staining confirmed the expression of UCC-specific markers [ Figure 2c and d]. UCC metastasis to the distal ileum was confirmed, and palliative chemotherapy with paclitaxel was administered. However, the patient died 5 months after the diagnosis of metastatic UCC complicated with refractory SBO.
DISCUSSION
Transitional cell carcinoma, more correctly known as UCC, is the most common type of bladder cancer (>90%) affecting the genitourinary (GU) tract. UCC is typically diagnosed in old male patients, with incidence peaks in the sixth and seventh decades of life. 5 UCC is associated with the highest recurrence rate and multiplicity among cancers. High-grade UCC refers to a high level of genetic instability, with similar biological properties to those of invasive UCCs and a higher risk of recurrence and progression. 6 During the later stages of this disease, tumors may metastasize to the common iliac chain and paraaortic lymph nodes, which are reflected as distant metastasis. When UCC metastasis to the GU tract occurs through the hematogeneous route, the lung, bones, liver, and adrenal glands are most commonly affected. 5 In the present case, the patient had high-grade UCC with regional lymph node invasion and LVSI, and hence, the risk of recurrence or distant metastasis was very high. Disease progression with common iliac chain invasion and distal ileum metastasis was likely the cause of the recurrent SBO.
UCC with distant metastasis to the gastrointestinal tract is very rare. Ten cases of UCC with small intestinal metastasis in Asia have been reported [ Table 1 ]. 7 Nine patients were male and one was female, aged between 60 and 80 years. Four patients, including the one reported here, had primary lesions in the ureter and had undergone nephroureterectomy. In our case, the patient presented with SBO caused by small intestinal metastasis of UCC, 1.5 year after he was diagnosed with high-grade UCC. Although postsurgical adhesion is the most common cause of intestinal obstruction, malignant bowel obstruction should also be considered in the differential diagnosis if the patient has a history of cancer.
Malignant SBO (MSBO) is a harrowing complication of cancer disease which denotes a poor prognosis and poor life quality of patients. However, how to improve patient's quality of life, relieve abdominal symptoms, and adequate nutrition support need to be considered. Hu and Yu reported that the use of small-bowel decompression tubes can ameliorate nutritional status, relieve symptoms, and decrease complications in patients with MSBO. 8 Jiang et al. stated that percutaneous needle decompression can be useful for the palliative treatment of MSBO. 9 On the other hand, Prost À la Denise et al. suggested that surgical intervention must be considered quickly after the failure of medical management of SBO. The authors found that less than half of the patients with a previous history of cancer whose SBO belonged to the malignant cause. They reported some meaningful predictors of a MSBO including: (I) incomplete obstruction, (II) acute onset, (III) temporary abdominal pain, (IV) a shorted time between primary cancer surgery and the first episode of obstruction, and (V) a known cancer recurrence. 10 In our patient, he presented with sudden onset, partial intestinal obstruction, and intermittent abdominal pain. These factors were maybe the hint of MSBO. A more conservative treatment may consider rather than surgery.
CONCLUSION
We describe a case of intractable SBO due to UCC with distal ileum metastasis, which was complicated with intestinal paralysis. Although very rare, the possibility of UCC metastasis to the gastrointestinal tract should be considered in the differential diagnosis of refractory intestinal obstruction and who had a history of UCC. Rigorously, history taking, physical examination, and image study can let clinicians figure out significant risk factors for SBO and help make decision to treatment direction. 
